Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study
- PMID: 17548679
- DOI: 10.1158/1055-9965.EPI-07-0089
Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study
Abstract
Objectives: The aim of the study was to examine the overall risk factors for epithelial ovarian cancer and according to histologic subtypes.
Materials and methods: Ovarian cancer cases and controls were recruited from 1995 to 1999, and personal interviews were conducted. A total of 554 cases and 1,564 randomly selected controls were included. The analyses were done using multiple logistic regression models.
Results: The overall risk of ovarian cancer decreased with ever being pregnant [odds ratios (OR), 0.40; 95% confidence intervals (CI), 0.30-0.55], with increasing pregnancies (OR, 0.63; 95% CI, 0.45-0.87 and OR, 0.51; 95% CI, 0.37-0.69 for two and three pregnancies as compared with one), and with older age at first and last pregnancy, respectively. Increasing years of ovulation was a very strong risk factor with a 7% to 8% increase in risk for each year of ovulation. Use of oral contraceptives (OR, 0.67, 95% CI, 0.53-0.85) and longer duration of use were associated with a decreased risk of ovarian cancer. Ever use of hormone replacement therapy increased the overall risk (OR, 1.30; 95% CI, 1.05-1.61). For all those variables, the effect was present for serous tumors, endometrioid tumors, and tumors of other histologies, but not for mucinous tumors. In contrast, current smoking was a risk factor only for mucinous tumors (OR, 1.78; 95% CI, 1.01-3.15) and increasing body mass index tended to increase the risk especially for mucinous and endometrioid tumors.
Conclusions: We confirmed already known risk factors for ovarian cancer, and we observed significant differences in the risk profiles between mucinous and nonmucinous tumors indicating different etiologies.
Similar articles
-
Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.Cancer Causes Control. 2006 Aug;17(6):821-9. doi: 10.1007/s10552-006-0022-x. Cancer Causes Control. 2006. PMID: 16783610
-
Risk factors for benign serous and mucinous epithelial ovarian tumors.Obstet Gynecol. 2007 Mar;109(3):647-54. doi: 10.1097/01.AOG.0000254159.75977.fa. Obstet Gynecol. 2007. PMID: 17329516
-
Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.Gynecol Oncol. 2001 Dec;83(3):575-85. doi: 10.1006/gyno.2001.6451. Gynecol Oncol. 2001. PMID: 11733975
-
Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.Acta Obstet Gynecol Scand. 2004 Sep;83(9):783-95. doi: 10.1111/j.0001-6349.2004.00550.x. Acta Obstet Gynecol Scand. 2004. PMID: 15315588 Review.
-
Oral contraceptives and ovarian cancer: an update, 1998-2004.Eur J Cancer Prev. 2006 Apr;15(2):117-24. doi: 10.1097/01.cej.0000179274.24200.9d. Eur J Cancer Prev. 2006. PMID: 16523008 Review.
Cited by
-
The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer.Health Sci Rep. 2022 Nov 22;5(6):e936. doi: 10.1002/hsr2.936. eCollection 2022 Nov. Health Sci Rep. 2022. PMID: 36439044 Free PMC article.
-
Statin use and risk for ovarian cancer: a Danish nationwide case-control study.Br J Cancer. 2015 Jan 6;112(1):157-61. doi: 10.1038/bjc.2014.574. Epub 2014 Nov 13. Br J Cancer. 2015. PMID: 25393364 Free PMC article.
-
Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis.Front Endocrinol (Lausanne). 2019 Dec 3;10:801. doi: 10.3389/fendo.2019.00801. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31849838 Free PMC article.
-
Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study.Br J Cancer. 2012 Jan 31;106(3):596-602. doi: 10.1038/bjc.2011.572. Epub 2012 Jan 5. Br J Cancer. 2012. PMID: 22223086 Free PMC article.
-
Association between Cigarette Smoking and Histotype-Specific Epithelial Ovarian Cancer: A Review of Epidemiologic Studies.Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1103-1116. doi: 10.1158/1055-9965.EPI-18-1214. Epub 2019 May 1. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31043418 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical